scholarly journals A Case of Esophageal Metastasis from Breast Cancer 10 Years after Mastectomy Treated by Video-assisted Thoracoscopic Subtotal Esophagectomy

Author(s):  
Keita KOUZU ◽  
Tomoyuki MORIYA ◽  
Hironori TSUJIMOTO ◽  
Tamio YAMAZAKI ◽  
Hideki UENO ◽  
...  
2009 ◽  
Vol 16 (7) ◽  
pp. 1982-1989 ◽  
Author(s):  
Hiroo Nakajima ◽  
Ikuya Fujiwara ◽  
Naruhiko Mizuta ◽  
Koichi Sakaguchi ◽  
Yasushi Hachimine ◽  
...  

1993 ◽  
Vol 54 (3) ◽  
pp. 646-650
Author(s):  
Taiji HASE ◽  
Naoyuki YANAGIDA ◽  
Makoto NISHIKAWA ◽  
Yukifumi KONDO ◽  
Junichi UCHINO ◽  
...  

2021 ◽  
Vol 15 (1) ◽  
Author(s):  
Sumadi Lukman Anwar ◽  
Widya Surya Avanti ◽  
Lina Choridah ◽  
Ery Kus Dwianingsih ◽  
Herjuna Hardiyanto ◽  
...  

Abstract Background Esophageal involvement and Horner’s syndrome are rare manifestations of breast cancer distant metastases that can pose a significant challenge in diagnosis and treatment. In addition to the more aggressive behavior of breast cancer diagnosed in young women, non-adherence to treatment is associated with increased risk of distant metastasis. Case presentation A 36-year-old Javanese woman presented to our institution with dysphagia, hoarseness, and frequent hiccups. In the 6 weeks prior to the current admission, the patient also reported tingling in the neck and shoulder, anhidrosis in the left hemifacial region, and drooping of the upper left eyelid. She was previously managed as tuberculoid laryngitis. Plain X-rays showed burst fractures of the cervical vertebrae and slight pleural effusion. Laryngoscopy revealed bowing of the vocal cords and liquid residue in the vallecula that was reduced upon chin tuck. Esophageal metastasis was confirmed with endoscopy showing thickening of the wall and positive cytology swab with ductal malignant cells. The patient had a history of breast cancer with a period of loss to follow-up of 4 years. Conclusions Physicians should consider potential distant metastasis of breast cancer to the esophagus and sympathetic nervous system of the neck particularly in a high-risk woman with presentation of dysphagia and manifestations of Horner’s syndrome.


1990 ◽  
Vol 51 (5) ◽  
pp. 946-950
Author(s):  
Masahiko MUROI ◽  
Misao YOSHIDA ◽  
Mitsuhiro OHMURA ◽  
Kumiko MONMA ◽  
Nobuhiro SAKAKI ◽  
...  

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. e12004-e12004
Author(s):  
C. A. Presant ◽  
L. Bosserman ◽  
F. Howard ◽  
B. Emilio

e12004 Background: Personalized Rx for patients (PTs) can improve response. Although archival tissue is available in all PTs, FTT testing of molecular, immunohistochemical, and/or chemosensitivity characteristics may be more optimal for TP than tissues obtained before previous Rx and/or new mets, and archival tissue is inadequate for cell culture information. This study was performed to determine the availability of FTT in a multi-site cancer center. Methods: Pts seen over 22 months were evaluated. PT clinical characteristics were evaluated to determine the prevalence of mets by site, and feasibility of biopsy (bx) for FTT by site. A bx algorithm for FTT was developed and quantified. Results: 26,794 successive PTs were evaluated. BrCa was present in 2043 (7.6%). Median age was 61 (range 27 to 98). Mets were present in only 174 (8.5% of BrCa) who had 256 sites involved (1.47 site per PT). 68% of PTs had multiple sites involved. Of PTs with multiple sites, 96 (81%) had 2, 16 (14%) had 3, and 6 (5%) had 4 sites involved. Single site was the pattern in only 9% of liver, 7% of lung, 32% of bone, 0% of adrenal 6% of skin, but 71% of brain mets. The most frequent sites of mets were bone (50%), lung (31%), liver (26%), brain (10%), skin or soft tissue (11%), lymph node (6%), and effusion/ascites (3.4%). In order to theoretically obtain FTT for development of a personalized TP based on an algorithm preferring in order local bx > para/thoracentesis, > non-osseous needle bx > video-assisted tissue bx > osseous bx, 18% of PTs would have had a local bx, 3% para/thoracentesis, 23% liver bx, 19% lung bx, 17% bone bx, and 12% would not have had a bx because of brain-only mets. Conclusions: Most BrCa PTs in oncology practices have only locoregional disease. Most PTs with mets have multiple sites. FTT acquisition would be feasible for 88% of PTs with mets for personalized TP, and in most the bx would be simple and non-invasive. However, tissue culture tests would necessitate a more invasive video-assisted bx in 42% of PTs. Physicians should consider additional bx to personalize TP when appropriate for improving outcomes. [Table: see text]


Sign in / Sign up

Export Citation Format

Share Document